Magenta Therapeutics Inc. (MGTA)
NASDAQ: MGTA
· Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM
Magenta Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.51M | -32.34M | -24.07M | -3.28M | -29.17M | -20.18M | -16.06M | -17.27M | -22.95M | -19.29M | -17.43M | -16.93M | -17.49M |
Depreciation & Amortization | 133K | -475K | -87K | n/a | 421K | 466K | 471K | -222K | 1.21M | 535K | 532K | 479K | 474K |
Stock-Based Compensation | 5.32M | 10.21M | 8.05M | 416K | 506K | 1.76M | 1.51M | 1.84M | 1.91M | 2.18M | 3.8M | 2.13M | 2.19M |
Other Working Capital | n/a | -2.28M | -1.35M | 188K | 1.16M | 935K | -1.07M | -345K | -1.42M | -348K | -1.29M | 1.44M | -611K |
Other Non-Cash Items | n/a | -15.72M | -12.05M | -3.6M | 12.13M | 664K | 818K | 1.53M | 115K | 78K | 198K | 221K | 306K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 18.97M | 19.57M | -79K | -19.49M | 596K | -541K | -2.74M | -21K | 806K | -1.17M | 1.09M | -2.26M |
Operating Cash Flow | -27.63M | -19.35M | -8.59M | -6.54M | -35.6M | -16.69M | -13.81M | -16.85M | -19.74M | -15.69M | -14.07M | -13M | -16.77M |
Capital Expenditures | -24K | 296K | 171K | n/a | -245K | -156K | -158K | -129K | -27K | -15K | -1.13M | -111K | -7K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -67.32M | -394.16M | -295.86M | n/a | -9.77M | -9.78M | -19.6M | -40.12M | -40.12M | -45.31M | n/a | n/a | n/a |
Sales Maturities Of Investments | 82.14M | 52M | -8M | 15M | 35M | 25M | 35M | n/a | n/a | 35M | 17.5M | 30M | 7.5M |
Other Investing Acitivies | n/a | -5.54M | -5.38M | 3.87M | 1.51M | 156K | n/a | 40.12M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.79M | -347.4M | -309.07M | 18.87M | 26.5M | 15.22M | 15.24M | -129K | -40.14M | -10.32M | 16.37M | 29.89M | 7.49M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -49.82M | -49.7M | 49.7M | n/a | 115K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 32K | 219.38M | 215.95M | n/a | n/a | 66K | 2.76M | 49K | n/a | 124K | 203K | 88.86M | 418K |
Financial Cash Flow | 161K | 205.85M | 166.24M | n/a | n/a | 66K | 2.76M | 49K | n/a | 124K | 203K | 88.86M | 418K |
Net Cash Flow | -12.68M | -39.61M | -28.73M | 12.33M | -9.1M | -1.4M | 4.2M | -16.93M | -59.88M | -25.89M | 2.5M | 105.75M | -8.86M |
Free Cash Flow | -27.65M | -19.05M | -8.42M | -6.54M | -35.84M | -16.84M | -13.97M | -16.98M | -19.77M | -15.71M | -15.2M | -13.11M | -16.78M |